COMPARE
DSP Banking & Financial Services Fund - Direct - Growth vs Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
DSP Banking & Financial Services Fund and Nippon India Pharma Fund are both in the Sectoral Fund category, from DSP Asset Managers Private Limited and Nippon Life India Asset Management Limited respectively. DSP Banking & Financial Services Fund has the lower expense ratio. See the full table and FAQ below for the complete real-data comparison.
Basics
DSP Banking & Financial Services Fund has the lower direct-plan expense ratio, by 0.19 percentage points.
| DSP Banking & Financial Services Fund - Direct - Growth | Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | |
|---|---|---|
| Category | Sectoral Fund | Sectoral Fund |
| AMC | DSP Asset Managers Private Limited | Nippon Life India Asset Management Limited |
| Benchmark | Nifty Financial Services TRI | BSE Healthcare TRI |
| NAV | ₹14.117 (2026-10-28) | ₹620.0717 (2026-10-28) |
| AUM | ₹2,014.128 Cr | ₹8,635.041 Cr |
| Expense Ratio (Direct) | 0.81% | 1% |
| Inception | 2023-11-20 | 2004-05-10 |
Returns
Risk Metrics
DSP Banking & Financial Services Fund has been the more volatile of the two by standard deviation.
| DSP Banking & Financial Services Fund - Direct - Growth | Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | |
|---|---|---|
| 3Y Sharpe Ratio | 0.32 | 0.61 |
| 3Y Alpha | 4.2022% | -2.6476% |
| 3Y Std Deviation | 15.5624% | 13.5522% |
| 3Y Calmar Ratio | 0.82 | 1.04 |
Portfolio Analytics
Nippon India Pharma Fund carries the higher portfolio P/E ratio (a rougher proxy for how richly the underlying holdings are valued) - see the table below for the full comparison.
| DSP Banking & Financial Services Fund - Direct - Growth | Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option | |
|---|---|---|
| P/E Ratio | 19.7956 | 39.6786 |
| P/B Ratio | - | 12.3627 |
| Dividend Yield | 0.7625% | 0.724% |
| Active Share | 53.04% | 40.74% |
| Portfolio Turnover | 64.8% | 15% |
| YTM | - | - |
| Duration (Macaulay) | - | - |
Punji Fund Health Score
DSP Banking & Financial Services Fund has the stronger Punji Quality grade of the two.
Frequently asked questions
Which has a lower expense ratio, DSP Banking & Financial Services Fund or Nippon India Pharma Fund?
DSP Banking & Financial Services Fund's direct-plan expense ratio is 0.19 percentage points lower than Nippon India Pharma Fund's. Over long holding periods, a persistent expense-ratio gap compounds into a materially different final corpus even if the two funds' gross returns are similar - it's one of the few fund attributes you can compare with total certainty upfront, unlike future returns, since the fee is contractually fixed rather than a historical estimate.
Which fund carries more risk, DSP Banking & Financial Services Fund or Nippon India Pharma Fund?
By standard deviation (a measure of how much a fund's returns swing around its own average), DSP Banking & Financial Services Fund has been more volatile than Nippon India Pharma Fund over the trailing window. Standard deviation captures total volatility in both directions - up and down - so a higher figure means bigger swings generally, not necessarily bigger losses specifically. Sharpe ratio (0.32 for DSP Banking & Financial Services Fund vs 0.61 for Nippon India Pharma Fund) is a better single measure of risk-adjusted return, since it weighs the return earned per unit of volatility taken rather than volatility alone.
Which has higher AUM, DSP Banking & Financial Services Fund or Nippon India Pharma Fund?
Nippon India Pharma Fund has ₹8,635 Cr in assets under management, versus ₹2,014 Cr for DSP Banking & Financial Services Fund. A larger AUM generally means deeper liquidity and lower per-unit fixed costs for the AMC to spread across investors, but an AUM that's very large relative to a fund's category and strategy (especially in small/mid cap categories, where the investable universe is smaller) can also make it harder for a manager to enter and exit positions without moving the price - bigger isn't automatically better, especially for less liquid categories.
Which fund has a longer track record, DSP Banking & Financial Services Fund or Nippon India Pharma Fund?
Nippon India Pharma Fund launched on 2004-05-10, making it older than DSP Banking & Financial Services Fund (launched 2023-11-20). A longer track record means more real market cycles (bull runs, corrections, rate cycles) the fund has actually navigated, which is useful context for judging consistency - but it isn't a guarantee of future performance, and a newer fund isn't automatically worse, especially if it's run by an experienced manager or team with a track record at a prior fund.
Data as of 2026-10-29. Source: AMFI disclosures via Punji. Not investment advice.